BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14567764)

  • 41. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
    Odlind V
    Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
    [No Abstract]   [Full Text] [Related]  

  • 42. The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible?
    Mueck AO; Seeger H
    Gynecol Endocrinol; 2008 Mar; 24(3):129-32. PubMed ID: 18335326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hormone replacement therapy and vessels: what's the story in 2007?].
    Chabbert-Buffet N
    J Mal Vasc; 2007 Dec; 32(4-5):190-1. PubMed ID: 17698308
    [No Abstract]   [Full Text] [Related]  

  • 45. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Estrogen replacement therapy and breast cancer].
    Bakken K; Alsaker E; Eggen AE; Lund E
    Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

  • 48. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long-term hormone substitution and risk of breast carcinoma: current status].
    Kuhl H; Runnebaum B; Schneider HP
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):M1-5. PubMed ID: 8852790
    [No Abstract]   [Full Text] [Related]  

  • 50. Breast cancer risk and the administration of human hormones. Part I. Hormone replacement therapy.
    Mann RD
    Adverse Drug React Toxicol Rev; 1992; 11(3):149-72. PubMed ID: 1391392
    [No Abstract]   [Full Text] [Related]  

  • 51. Hormone replacement therapy and breast cancer.
    Kenemans P; Stampfer M
    Eur J Obstet Gynecol Reprod Biol; 1996 Jul; 67(1):1-4. PubMed ID: 8789741
    [No Abstract]   [Full Text] [Related]  

  • 52. Hormone replacement therapy and breast cancer.
    Kemp JF; Baber RJ
    Med J Aust; 1993 May; 158(10):722. PubMed ID: 8338542
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same. Do all the patients have the same characteristics?].
    Mathelin C; Brettes JP
    Gynecol Obstet Fertil; 2007 Jun; 35(6):502-3. PubMed ID: 17543563
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hormone therapy and breast cancer].
    Olsen J
    Ugeskr Laeger; 2003 Sep; 165(38):3631-2. PubMed ID: 14556398
    [No Abstract]   [Full Text] [Related]  

  • 55. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone therapy and breast cancer risk.
    Foidart JM; Desreux J; Pintiaux A; Gompel A
    Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormone therapy: maximizing the benefits.
    Heikkinen J
    Gynecol Endocrinol; 2006 Mar; 22(3):160-2. PubMed ID: 16835079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Concerning "risks and benefits of long-term treatment with estrogens" by T.M. Mack and R.K. Ross, Schweiz. med. Wschr. 1989; 119:1811-1820].
    Sitruk-Ware R
    Schweiz Med Wochenschr; 1990 Oct; 120(43):1608-10. PubMed ID: 2251476
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug delivery systems for hormone therapy.
    Yoo JW; Lee CH
    J Control Release; 2006 May; 112(1):1-14. PubMed ID: 16530874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.